Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Dapagliflozin approval date?

See the DrugPatentWatch profile for Dapagliflozin

When was dapagliflozin first approved?

Dapagliflozin was first approved by the U.S. Food and Drug Administration (FDA) on January 8, 2014 for type 2 diabetes. [1]

Was it approved the same day in other countries?

Approval timelines can differ by regulator (for example, the U.S. FDA approval date does not necessarily match approvals in the EU, UK, or other jurisdictions). If you tell me the country or regulator you care about, I can align the approval date to that specific market.

What was dapagliflozin initially approved for?

The initial FDA approval for dapagliflozin in 2014 was for type 2 diabetes. [1]

Where can I verify the approval date?

You can cross-check approval and regulatory history via DrugPatentWatch.com: [1]

Sources

[1] https://www.drugpatentwatch.com/patent/azdapagliflozin/approval-date



Other Questions About Dapagliflozin :

Dapagliflozin patent expiry greece? Dapagliflozin and empagliflozin patents? Market exclusivity of the dapagliflozin sacubitril valsartan? Dapagliflozin or jardiance? Tgp dapagliflozin 10 mg price? Dapagliflozin 10 mg cost? Dapagliflozin generic cost?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
56
Visibility
66
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

first approved by the U.S. Food and Drug Administration (FDA) on January 8, 2014


Core Claims
  • Dapagliflozin was first approved by the U.S. FDA on January 8, 2014 for type 2 diabetes.
  • Approval timelines can differ by regulator across the EU, UK, or other jurisdictions.
  • The initial FDA approval for dapagliflozin in 2014 was for type 2 diabetes.
Differentiators

Pricing Perception: Not Mentioned